Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">ARC1779: Phase IIa started</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

Archemix began a double-blind, placebo-controlled, international Phase IIa trial to evaluate intravenous ARC1779 in about 100 patients. ......

Cardiovascular

Hematology

Ophthalmic

ARC1779: Phase IIa started

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts 

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data Coverage

BCIQ Data

All Events

East-West Healthcare Reception

Bio€quity Europe

Grand Rounds — U.S.

Grand Rounds — Europe

The BioCentury-BayHelix China Healthcare Summit

China Healthcare Summit

3rd Biotech CEO & Investor Reception

At the East-West Summit, you will meet key players looking to globalize innovation from across Asia.